Vital Transformations Study Regarding White House Drug Pricing and SMART Act Released
The Vital Transformations study was released this week, and it estimates that there would be more than 235 fewer FDA approvals of new medicines for patients battling cancer, neurological, and rare and infectious diseases over the next decade as well as 15,714 lost jobs for Georgia workers if proposals to expand federal government-mandated drug pricing policies are…
Read MoreIndustry Leader and Globally Recognized Patient Advocate John F. Crowley Appointed to Lead BIO as President & CEO
Biotech entrepreneur, company founder, tireless patient advocate, and U.S. Navy combat veteran will guide the life science industry in its mission to feed, fuel and heal the world December 5, 2023 | The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President…
Read MoreLarge Majority of Americans Say Consideration of Clinical Trial Participation Should be a Part of Regular Health Care
New National Public Opinion Survey Reveals Willingness to Participate in Clinical Trials; Importance of Trials Reflecting the Population; Concerns About Sharing Personal Health Information Have Grown Arlington, VA – December 5, 2023 – According to survey findings released today, an overwhelming majority of Americans (87%) agree that health care professionals should discuss clinical trials…
Read MoreMicron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles
November 16, 2023 November 16 2023, ATLANTA– Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced a $23.6 million grant from the Bill & Melinda Gates Foundation that will fund mass production of needle-free vaccines. The manufacturing facility will…
Read MoreEchoing the Optimism for Medtech and Bioscience Venture Investment in the Southeast
In the final session of the 2023 Georgia Life Sciences Summit, four life science venture investors joined Radyus Research CEO Marta New to discuss best practices and errors to avoid for early stage life science companies building an “investment stack” along with their perceptions of the southeast life science innovation ecosystem and its “investability.” If…
Read MorePutting the Tech in Bio & MedTech
The convergence of life and data sciences promises to dramatically accelerate the pace of innovation and drug development. Georgia is emerging as a leader in combining these fields to address some of the most challenging problems in life sciences. While generative AI is not ready to support clinical decision making, “Intelligent call centers, appointment setting,…
Read MoreLife Science Nation bringing a medtech investor event to Atlanta in early 2024
In September, Life Science Nation announced “RESI South’ in partnership with a newly formed coalition of life science associations representing Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. The conference will come to Atlanta, GA, in [early] 2024. RESI South is expected to draw a crowd of over 500 bioscience and medtech entrepreneurs…
Read MoreJohns Creek Named First “BioReady Community” in Georgia
As the life sciences sector in Georgia continues to grow at a rapid pace, the need for bioready sites grows. As just the second state in the country to formally adopt such a program, the BioReady Community program will allow Georgia’s municipalities to showcase biotech-zoned science parks, streamline permitting, build a robust infrastructure, and identify…
Read MoreReshaping the narrative on biopharma innovation with BIO Board Chair Dr. Ted Love
Dovetailing closely on access, advocacy, policy and innovation, BIO Board Chair and founder of Global Blood Therapeutics Dr. Ted Love discussed his mission oriented journey in the life sciences in the day’s keynote. This work continues with the need to reshape the narrative around biopharma innovation, access, cost and value. “Drug cost is not a…
Read MoreAccess and Advocacy: “Share the Savings”
Americans want policymakers to see lowering out-of-pocket costs for health care as a top priority. Putting pharma and its innovators who invest billions of dollars in R&D for therapies that improve outcomes and save lives in villainous crosshairs is easy to understand and politically expedient, but misguided. In 2021, West Virginia became the first state…
Read MoreAccess and Innovation: Georgia Bio Recommits to Industry as a new c6 & New GRA CEO Opens the 2023 Georgia Life Sciences Summit
Having recently renewed our commitment to advocating for, educating and connecting our member enterprises and stakeholders, the 2023 Georgia Life Sciences Summit by Georgia Bio brought more than 300 members of the ecosystem together in Sandy Springs on November 1st. We reconnected with friends and colleagues, made new connections, learned from academic, industry and elected…
Read More